Drugs News and Research

RSS

Development of multivalent next-generation vaccine strategy against ancestral SARS-CoV-2 and emerging variants

A recent study demonstrated that intranasal (i.n.) delivery of COVID-19 vaccine in murine models elicits greater immune responses against the wildtype SARS-CoV-2 and its variants.

14 Feb 2022

Researchers identify a powerful combination of antivirals to treat COVID-19

Researchers at the University of Maryland School of Medicine and University of Pennsylvania Perelman School of Medicine have identified a powerful combination of antivirals to treat COVID-19.

14 Feb 2022

New research could deliver a breakthrough for kids suffering from severe form of genetic epilepsy

New research from the University of South Australia could deliver a breakthrough for children suffering one of the most severe forms of genetic epilepsy, reducing the frequency of their seizures and improving their quality of life.

14 Feb 2022

Nitazoxanide shows promise for COVID-19 treatment in animal model

In a recent study posted to the bioRxiv* pre-print server, researchers demonstrated that Nitazoxanide (NTZ), an oral drug, broadly inhibits replication of several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) in preclinical models of infection.

13 Feb 2022

New multiple-shot electroporation device could enable low-cost, effective cancer drug delivery

Researchers from the Singapore University of Technology and Design (SUTD) have developed a microsize-gap multiple-shot electroporation (M2E) device that could improve the effectiveness of delivering cancer drugs at a lower cost, globally.

12 Feb 2022

Researchers find unprecedented rise in HIV incidence rate among people who inject drugs in Tijuana

At the February 11, 2022 opening of the Conference on Retroviruses and Opportunistic Infection, researchers at University of California San Diego School of Medicine presented data that suggests a new HIV outbreak in Tijuana, Mexico, driven in part by "drug tourism" unabated by the closure of the international border due to the COVID-19 pandemic.

12 Feb 2022

Study reveals new physiological mechanisms linking chronic pain to disrupted eating behavior

It has long been known that there is an association between food and pain, as people with chronic pain often struggle with their weight. Researchers at the Del Monte Institute for Neuroscience may have found an explanation in a new study that suggests that circuitry in the brain responsible for motivation and pleasure is impacted when someone experiences pain.

12 Feb 2022

New class of compounds can improve multiple aspects of metabolic syndrome, mice study shows

A study in mice - led by researchers at Washington University School of Medicine in St. Louis - shows that a new class of compounds the scientists developed can improve multiple aspects of metabolic syndrome.

12 Feb 2022

Spatial transcriptomics-driven gene mapping offers new insights into inflammatory bowel disease

Using a technique called spatial transcriptomics, researchers at Karolinska Institutet in Sweden have analyzed the gene expression in the mouse colon and created a map showing where in the tissue individual genes are expressed.

12 Feb 2022

Liver cirrhosis has higher hospitalization and in-hospital mortality rates in Germany

In Germany, liver cirrhosis has the highest mortality rate of any chronic disease requiring hospital admission. When diagnosed as a comorbidity of other chronic diseases, liver cirrhosis at least doubles the mortality rate.

12 Feb 2022

Molecular cage helps researchers to get atomic-level details of key cancer protein

Acute myeloid leukemia (AML), the American Cancer Institute estimates, will affect more than 20,000 Americans this year and kill more than 11,000 of them.

11 Feb 2022

First unbiased proteome scale study expands the number of known transcriptional activators

Also known as transcriptional activators for their ability to induce transcription of genes into RNA messages, these proteins are essential for the cells to function properly. Yet little is known about these proteins, and it wasn't clear how many activators there might be in human cells – until now.

11 Feb 2022

The impact of COVID-19 on people with systemic autoimmune rheumatic diseases

A survey demonstrated that patients with systemic autoimmune rheumatic diseases commonly experience augmented disease severity and disrupted treatment regimens of disease-modifying antirheumatic drugs after acute COVID-19 course.

11 Feb 2022

Challenges in safely deprescribing common anticholinergic drugs

Medications with anticholinergic properties have been consistently associated with a wide range of adverse outcomes for older adults including cognitive impairment, yet these drugs continue to be commonly prescribed for depression, urinary incontinence, irritable bowel syndrome and Parkinson's disease.

11 Feb 2022

What are taxpayers spending for those ‘free’ covid tests? The government won’t say.

The four free covid-19 rapid tests President Joe Biden promised in December for every American household have begun arriving in earnest in mailboxes and on doorsteps.

11 Feb 2022

Showcasing STEM Women in Medical Science

Every year, the UN celebrates the International Day of Women and Girls in Science. For 2022, the focus is placed on recognizing the role women and girls play in STEM as beneficiaries and as agents of change.

11 Feb 2022

Alkem signs license agreement with Harvard to develop, commercialize new technology for treating ischemic conditions

Alkem Laboratories Limited, an Indian multinational pharmaceutical company, has signed a license agreement with Harvard University's Office of Technology Development enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease (PAD), and other injuries caused by vascular disease.

11 Feb 2022

Drugs News and Research

Development of multivalent next-generation vaccine strategy against ancestral SARS-CoV-2 and emerging variants

Researchers identify a powerful combination of antivirals to treat COVID-19

New research could deliver a breakthrough for kids suffering from severe form of genetic epilepsy

Nitazoxanide shows promise for COVID-19 treatment in animal model

New multiple-shot electroporation device could enable low-cost, effective cancer drug delivery

Researchers find unprecedented rise in HIV incidence rate among people who inject drugs in Tijuana

Study reveals new physiological mechanisms linking chronic pain to disrupted eating behavior

New class of compounds can improve multiple aspects of metabolic syndrome, mice study shows

Spatial transcriptomics-driven gene mapping offers new insights into inflammatory bowel disease

Liver cirrhosis has higher hospitalization and in-hospital mortality rates in Germany

Molecular cage helps researchers to get atomic-level details of key cancer protein

First unbiased proteome scale study expands the number of known transcriptional activators

The impact of COVID-19 on people with systemic autoimmune rheumatic diseases

Challenges in safely deprescribing common anticholinergic drugs

What are taxpayers spending for those ‘free’ covid tests? The government won’t say.

Showcasing STEM Women in Medical Science

Alkem signs license agreement with Harvard to develop, commercialize new technology for treating ischemic conditions

Scientists discover a new class of potential drug targets for neurodegenerative diseases

Novel molecule shows ability to inhibit the replication of all coronaviruses

Drugs used to increase insulin signaling may be effective therapeutic strategy for autism

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News